For the 2nd time, Ovesco Endoscopy USA has been awarded the Innovation in Business by
Technical success (lesion reached and resected) was achieved in 94.4 %. R0 resection was achieved
Ovesco Messestand
Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) 2019 together with the
After moving to its new company headquarters in the Technology Park Tuebingen at the beginning
Pooled durable clinical success proportions of OTSC use were 87.5 % in hemorrhage, 81.4 %
New Ovesco company building in the construction phase
ovesco Endoscopy AG moved to its new headquarters on April 29, 2019 and will thus
Prospective data from 51 FTRD-procedures shows technical success in 88 % (45/51) and a R0-resection
The AWC was used in 8 patients with GI lesions 17-45 mm (average 35.9 mm)
Ovesco is proud to announce that both the OTSC® System and the remOVE System including
6 consecutive T1-ERC patients underwent FTRD application which resulted in complete endoscopic resection in all